A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Clinical trial NCT03887455 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03887455
- Sponsor
- Eisai Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2029-06-30
- Enrollment
- 1906
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.